Earnings Forecast Radar: J.C. Penney, Groupon, Pfizer, Allscripts, Freeport-McMoRan, and Morgan Stanley

Nov 12, 2012, 09:00 ET from EarningForecast.com

VANCOUVER, British Columbia, Nov. 12, 2012 /PRNewswire/ -- EarningForecast.com has issued consensus earnings forecast reports and equity research for the following companies: J.C. Penney (NYSE: JCP), Groupon (NASDAQ: GRPN), Pfizer (NYSE: PFE), Allscripts (NASDAQ: MDRX), Freeport-McMoRan (NYSE: FCX), and Morgan Stanley (NYSE: MS).

(Logo: http://photos.prnewswire.com/prnh/20121030/HK02457LOGO )

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

J.C. Penney Company, Inc. (NYSE: JCP): For fiscal third quarter ended October 27, 2012, J.C. Penney Company, Inc. (NYSE: JCP) reported net loss of US$123 million (or US$0.56 per share), compared with net loss of US$143 million (or US$0.67 per share), in the same quarter of 2011. Shares of J.C. Penney tumbled US$1.05 (-4.84%) to US$20.64 on hefty volume of 41.54 million shares, above its average volume of 6.33 million shares. Observing comprehensive analysis of J.C. Penney could help investors avoid big lost in investment. Check JCP earnings forecast report below.

Read Full Report: http://www.earningforecast.com/PR/111212A/JCP/JCPenney.pdf

Groupon Inc. (NASDAQ: GRPN): Abnormal trading volume of Groupon Inc. (NASDAQ: GRPN) was found on November 9 reaching 116.35 million shares, 9 times heavier than usual day trading. At the close of the trading day, shares of Groupon tumbled nearly 30% to US$2.76. GRPN made a new 52-week low of US$2.71 in the session. Observing comprehensive analysis of Groupon could help investors avoid big lost in investment. Add Groupon earnings forecast report into your watch list now.

Read Full Report: http://www.earningforecast.com/PR/111212A/GRPN/Groupon.pdf

Pfizer Inc. (NYSE: PFE): Pfizer Inc. (NYSE: PFE) shares began the trading session with a price of US$24.06 and throughout the session climbed to a high of US$24.42. When day-trade ended, the stock finally advanced 0.04% to US$24.17. The company's 52-week range remained US$18.15 to US$26.09 with its market capitalization touching US$180.54 billion. Investors may want to find out where PFE will go from here. Observing comprehensive Pfizer earnings forecast report here.

Read Full Report: http://www.earningforecast.com/PR/111212A/PFE/Pfizer.pdf

Today EarningForecast.com also observed abnormal trade volume for the following companies; Check out the consensus earnings forecast reports below:

Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX):

Read Full Report: http://www.earningforecast.com/PR/111212A/MDRX/Allscripts.pdf

Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX):

Read Full Report: http://www.earningforecast.com/PR/111212A/FCX/FreeportMcMoRan.pdf

Morgan Stanley (NYSE: MS):

Read Full Report: http://www.earningforecast.com/PR/111212A/MS/MorganStanley.pdf

About EarningForecast.com:

EarningForecast.com focuses on tracking and monitoring company Earnings Data for top market movers in US stocks market. EarningForecast.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:
Please visit: EarningForecast.com/disclaimers/index.php for details.

SOURCE EarningForecast.com